The high wave will become a large player in the German medical center with the acquisition of shares in the Remexian Pharma GMBH
In the last 12 months, Remexian has income 65 million euros income
Remexian sold 7 tons of cannabis flower in the quarter of 2025, which is 43 tons of 16% imported to Germany in the quarter
Calgary, ABD, August 14, 2025 / PRNEWSWIRE / – High Tide Inc. (“High Termosity” or “Company”) (NASDAQ. HITI) (FSE: PHARMA GMBH (“Remexian”), 27.2 million euros (“transaction”) and will have an option to obtain the rest of interest in Remexia.
It was founded in 2018. Among the buyers of all Germany’s doctors, Remexian has one of the most popular in the world, which is currently licensed from 19 countries, including Canada, who represents about 33% of their total imports to Germany. Taking into account more than $ 1.9 billion from Canadian Canadian sales, a high channel has a Canadian shopping expertise and relationships to make this transaction significantly increase the Canadian Canadian department in Germany.
“Remexian is ideal for us, not only prices, but also with its operational approach, which prevents the highest price team. Said Raj Grover, the founder and CEO of the High Channel.
“With this high-quality acquisition, it’s about $ 100 million to significant EBITDA, we will talk about more affordable prices, which are imported to the highest quality brands,” Mr. Gurverer added.
“We are truly energy with a strong certigion that we have found with a high wave, the impressive scale of which enhances our influence in Germany,” said Remexyan co-founder Marcus Wenner. “Our two companies have deliberately have a strategic approach to becoming leaders in our relevant markets.
In April 2024, the demand for medical cannabis continued to accelerate in the country since the adoption of the German consumer Act of Germany. Over the past year, the number of medical cannabis has sharply increased by 250,000 to about 900,000 to 1 billion euros (BFAMM). 2025 (37.5 tons) and twelve months roll in total 134 tons, maintaining its place as the world’s largest medical importer. The growth of demand has also stimulated the position of Canada as a leading global exporter, the country’s German imports, about 36 tons in the first six months of 2025.
The Remexian, led by Francesco Baghan and Stefan Adome, is a leader in German Medical Cannabis, with an annual income, and 43 tons of 16 million euros and 15 million euros and a quarterly imported in Germany.
When the acquisition concluded, the company considered the potential of changes in Germany’s medical cannabis. The company believes that even if the restrictions are posted on telemedicine and postpone, which is subject to a long-term legislative review, the market will continue to grow after the adjustment period.
___________________________
Alcalculation agreements based on REMEX sales data and import numbers, which were publicly released by BFARM.
Oursource. War of flowers’ prices. German boom, the reality of Great Britain
³SOURCE: BFARM (Q2 2025 Update)
Alcalculation agreements based on REMEX sales data and import numbers, which were publicly released by BFARM.
Deal details
The transaction is subject to the wing length of time, among other things, it is necessary to exchange TSX enterprise (“TSXV”) and other customs conditions and are expected to be closed in the coming weeks. This implies a 53.4 million euros app that represents the 3,64065 times an annual Ebitda, which was created in six months of March 31, 2025, and is subject to certain adjustments based on working capital and closure. For 51% of the acquired equality, the preliminary estimated price of 27.2 million euros will be satisfied as follows:
42% of high-tidal tidal shares (“Ri-High Shares”) Price in US $ 2.1912, presenting the average average price for NASDAQ for NASDAQ.
29% cash.
29% of loans from sellers (“Credit”). The loan will ripen on December 31, 2029, annual annual interests (paid quarterly) will lead to a pre-payment company without penalty.
In addition to the above, the Remexian owners agreed to provide a high-channel option that acquires the remaining interests remaining in the Remexian through high tidal tide (“Call version”). The call option will be implemented at any time for a five (5) years of closing twenty four (24) monthly anniversary (“term” of the call version). The call option is carried out for the value of the enterprise, which is equal to the 12th Tebit Date of the Adjusted EBITDA, if the call version is performed in the first twelve (12) month of the call version. In addition, the high channel agreed to provide Remember owners to reset the remaining interests in high tidal lecture. Taking into account the option or set version, given the case, it will be satisfied with the Cash and High Combination Character at the discretion of the high wave. The call option has a minimum price of 15 million euros, and is subject to at least 40% of the payment of minimum cash, and the installed version is subject to at least 30% cash.
Any high levels related to the transaction are subject to four months and one day of stateration.
About a high wave
High Tide, Inc. is a leading community, retail Cannabis, developed to unleash the full cost of the world’s most powerful factory. The whole subsidiary of it, Canna Kabana, is the second largest brand of Cannabis in the world. High wave (HITI) is unique around cannabis consumer, fully diversified and fully integrated with all components of cannabis, including:
Bricks & Mortar Retail. Canna CABANA is Canada’s largest retail network in Canada, 203 Current places that pass through British Columbia, Alberta, Saskakateva, Manitoba, Ontario. In 2021, Kanina Cabana became the retail sale of the Cannabis Discount Club in the world.
Retail innovation. Fastendr ում is a unique and fully automated technology that uses retail kiosks to facilitate better purchase experience with observation, order and pickup.
Consumption accessories. The high wave operates the world’s leading e-commerce platforms, including grasscity.com, Smokecartel.com, DailyHighclub.com and Dankstop.com.
Brands. The list of HIGH Wave Industry and Consumer Brand includes Bud ™, Daily High Club Wea, Daily High Club ™, Vodka Glass Pass ™, Donezilla ™, Atomik ™ etc.
CBD. High channel continues to develop consumer CBD capabilities via Nuleafnaturals.com, fabcbd.de and brabscbd.co.uk.
Wholesale distribution. The high wave keeps the category of cannabis through wholesale solutions through Valiant.
Licensing. The high channel continues to push the culture of Cannabis through fresh partnership and license agreements under the name of the famous brandz.
The high tide is consistently moving forward before the fourth year in a row was named one of the best growing companies in Canada in 2024, as well as for the fastest growing companies in 1023. Tide, visit www.hightideinc.com. Do not miss high pages of high tidal tide in Sedan and Edgar for investment.
NCV NewsWire aims to treat high-quality content and information about cannabis companies by New Cannabis Ventures to help our readers make noise and remain the most important cannabical business news. NCV Newswire is hand treated by hand and is not automated. Have secret news tip. Contact:A number
You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.
friends,
Many more cannabis companies reported Q1 financials this week. While NCV did not run any of those press releases, all data has been updated in the New Cannabis Ventures Public Cannabis Company Revenue & Income Tracker. The largest companies reporting in US dollars all reported, and the eleven companies that reported for the Q1 ended in March (excluding Tilray Brands, which is due to report its Q4 later this month) saw an average year-over-year revenue increase of 31% in their cannabis businesses.
Excluding Vireo Growth, that average comes to -0.7%, which is lower, especially after accounting for inflation, and a sign of continued challenges for the hemp industry. Speaking of Vireo, I’ve pointed out how investors didn’t care, and they still don’t. An average of just 375,000 shares traded per day over the past month, and the stock, which closed at $0.415, continues to trade off the level of its late 2024 capital raise and the price at which the company issued shares to make multiple acquisitions.
April was a big month for hemp stocks, but prices fell in May. The NCV Global Cannabis Stock Index rose 8.8% to 5.70 in April, but fell 2.8% to 5.54 in May. The year-to-year change of this index, which now covers 23 stocks, was -15.9%. Since its peak in early 2021, the GCSI is down 94%. Many are excited about the medical cannabis realignment that took place in April, although it remains unclear whether cannabis will be completely overhauled. The Department of Justice will hold hearings in late June to discuss adult-use cannabis, and it could be. If so, 280E tax would be removed, and this would be very good. I’ve written a lot about this since late 2022 when I highlighted it The potential end of 280E as a major catalyst.
The investor base in cannabis stocks has shrunk due to capital losses and fewer people interested in the sector. Institutions were more interested in high prices and maybe they would enter the field. 280E remains a big story, and not only is it being delayed by the limited realignment that’s already been completed, it’s unclear how unpaid taxes from the last few years will be treated.
NCV has stopped publishing most cannabis news, although we continue to update the financial calendar as well as the earnings rankings. After more than 10 years with NCV and more than a dozen years with 420 Investor, I am in the process of moving on. This is probably the last weekly newsletter. I’ve appreciated sharing the news and my views here, and I want to wish everyone the best. Hopefully, 280E taxation will be fully completed and the bear market that began in early 2021 for the hemp sector will be over.
Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
You are reading this week’s edition of New Cannabis Ventures, a weekly magazine we have published since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve, as well as links to the most important news of the week. We no longer email them like we used to, but post this and all newsletters on our website here.
friends,
The New Cannabis Ventures Global Cannabis Stock Index edged up slightly in May, rising 1.1% to 5.76. Compared to the previous year, it decreased by 12.6%. The index, recalculated as of the end of the first quarter, is up 9.9% so far in the second quarter, lagging the S&P 500’s 12.8% gain. Here are the earnings of the 23 names currently in the index (SMG was dropped in late April after the sale of Hawthorne Gardening):
MSOs are very much higher as the rally approaches the discussion of the big transformation announcements on 4/22 and beyond. There are currently six MSOs and two of them have been promoted. The rest rose, and the average of the six was 38.1%. The AdvisorShares Pure US Cannabis ETF ( MSOS ) has rallied 48.5% since the end of March and is now up 11.7% year-to-date in 2026. Both GCSI names have fallen sharply, and the index has a total of seven double-digit gains in Q2, with six MSOs and Canopy holding investments. 14 of the 23 names returned less than GCSI.
As readers are probably aware, the US reclassified medical cannabis from Schedule I to Schedule III on 4/23, and that will go away. 280E tax for some of the businesses of cannabis companies. The Department of Justice will hold a hearing in late June to determine possible rezoning for adult use. If it passes, all 280E taxation will end, which is a good thing for cannabis companies and their investors, as well as the subsidiaries that serve them. It is not yet known what the outcome will be, and it is not yet known how past 280E taxes that have not been paid but are carried as liabilities (and not debt) will be handled. Also, there is no conclusion yet on SECURITY banking or the possibility of a raise.
NCV has stopped publishing news, although we continue to update the financial calendar as well as the earnings rankings. After more than 10 years with NCV and more than a dozen years with 420 Investor, I am in the process of moving on. I’ve appreciated sharing the news and my views here, and I want to wish everyone the best. Hopefully, the 280E taxation will end and the bear market that started in early 2021 for the hemp sector will come to an end.
Sincerely,
Alan:
This week’s newsletter is sponsored by the Paul E. Saperstein Co.
Massachusetts hemp production equipment for sale
On May 12, Middlesex Integrative Medicine, Inc.’s equipment is being auctioned online in Leominster, Massachusetts at 10:00 a.m. ET. All applications must be submitted online. Learn more Of the secured party’s sale of all assets of this cultivation equipment.
Interested parties may contact Paul Cotto at 617-227-6553 or email pcotto@pesco.com:.
New Cannabis Ventures publishes curated articles as well as exclusive news. Here is what we have published in the last 2 weeks.
Stay on top of the most important communications from public companies by watching what’s coming cannabis investor calendar.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
Statistics Canada has released February retail sales for the country, with Cannabis sales are declining from January levels, down 7.9% from the previous month to C$440.5 million. The sequential decrease increased by 2.0% on a daily basis due to fewer days than in the previous month. January, originally reported at C$466.1 million, was revised higher to C$478.2 million. February sales rose 7.9% from a year ago, down 9.4% from last month, and 8.3% in May and 7.5% in June, but better than last year’s slowest growth rate since legalization -0.9% in September 2024 due to the BC strike. Total sales are expected to increase by 4.5% to C$5.39 billion in 2024 and by 4.1% to C$5.62 billion in 2025. So far in 2026, sales are up 8.6%.
An increase in the number of shops, as well as a fall in the prices of flowers that attract consumers from the illegal market, have boosted sales. In Ontario, the most populous province, sales fell 11.4% from January and 3% from a year ago. Alberta was down 10.2% from January, but up 1% from a year ago. British Columbia was up 3.7% from January and up 33% from a year ago, while Quebec was down 9.6% from January but up 30% from a year ago.
March sales data will be released on May 22.
Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El
